Joy Liu - 29 Apr 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
SVP, General Counsel
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
29 Apr 2022
Net transactions value
-$33,049
Form type
4
Filing time
03 May 2022, 16:28:33 UTC
Previous filing
28 Feb 2022
Next filing
18 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Sale $4,647 -17 -0.12% $273.37 14,437 29 Apr 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale $11,265 -41 -0.28% $274.75 14,396 29 Apr 2022 Direct F1, F2, F4
transaction VRTX Common Stock Sale $8,269 -30 -0.21% $275.62 14,366 29 Apr 2022 Direct F1, F2, F5
transaction VRTX Common Stock Sale $6,088 -22 -0.15% $276.72 14,344 29 Apr 2022 Direct F1, F2, F6
transaction VRTX Common Stock Sale $2,780 -10 -0.07% $278.04 14,334 29 Apr 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1.
F2 Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $273.37 (range $273.13 to $273.87).
F4 Open market sales reported on this line occurred at a weighted average price of $274.74 (range $274.20 to $275.14).
F5 Open market sales reported on this line occurred at a weighted average price of $275.62 (range $275.22 to $276.19).
F6 Open market sales reported on this line occurred at a weighted average price of $276.72 (range $276.31 to $277.06).